


Searching News Database: Forward Ventures
HSMN NewsFeed - 4 Apr 2017
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
HSMN NewsFeed - 12 Mar 2012
HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing
HemaQuest Pharmaceuticals Raises $13 Million in Series B Extension Financing
HSMN NewsFeed - 7 Dec 2010
La Jolla Pharmaceutical Company Announces Appointment of Dr. Bertrand C. Liang to Board of Directors
La Jolla Pharmaceutical Company Announces Appointment of Dr. Bertrand C. Liang to Board of Directors
HSMN NewsFeed - 17 Feb 2010
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome
HSMN NewsFeed - 18 Mar 2008
LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round
LigoCyte Pharmaceuticals Finalizes Agreement for $28M Series 'C' Financing Round
HSMN NewsFeed - 18 Dec 2007
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
Forward Ventures Joins Series A Syndicate for Newly Formed Altair Therapeutics
HSMN NewsFeed - 25 Jul 2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
HSMN NewsFeed - 22 Mar 2007
Sanarus Medical, Inc. Appoints John F. Howe as President and Chief Executive Officer
Sanarus Medical, Inc. Appoints John F. Howe as President and Chief Executive Officer
HSMN NewsFeed - 13 Dec 2006
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
HSMN NewsFeed - 5 Dec 2006
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
HSMN NewsFeed - 29 Jun 2006
FDA Grants Fast Track Designation for TargeGen TG100-115 Cardiovascular Compound
FDA Grants Fast Track Designation for TargeGen TG100-115 Cardiovascular Compound
HSMN NewsFeed - 17 May 2006
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Cabrellis Pharmaceuticals Corporation Announces Corporate Launch and Founding Management Team
Additional items found! 18
Members Archive contains
18 additional stories matching:
Forward Ventures
(Password required)
Forward Ventures
(Password required)
